Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chantal Alexia Neutzler"'
Autor:
Anirban Maitra, Alexandre Reuben, Chantale Bernatchez, Marie-Andree Forget, Donastas Sakellariou-Thompson, Tina Cascone, Annikka Weissferdt, Jianjun Zhang, Boris Sepesi, Ignacio Wistuba, Ara A Vaporciyan, Marcelo V Negrao, Lorenzo Federico, John V Heymach, Don L Gibbons, Cara L Haymaker, Junya Fujimoto, Jack A Roth, Parin Shah, Peixin Jiang, Roohussaba Khairullah, Yan Long, Shiaw-Yih Lin, Meredith L Frank, Chantal Alexia Neutzler, Chi-Wan B Chow, Kyle Gregory Mitchell, Daniel J McGrail
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Background Adoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TIL) yielded clinical benefit in patients with checkpoint blockade immunotherapy-refractory non-small cell lung cancer (NSCLC) prompting a renewed interest in TIL-ACT. This pr
Externí odkaz:
https://doaj.org/article/695b65690403434c9d38fde087d200d1
Autor:
Parin Shah, Marie-Andrée Forget, Meredith L Frank, Peixin Jiang, Donastas Sakellariou-Thompson, Lorenzo Federico, Roohussaba Khairullah, Chantal Alexia Neutzler, Ignacio Wistuba, Chi-Wan B Chow, Yan Long, Junya Fujimoto, Shiaw-Yih Lin, Anirban Maitra, Marcelo V Negrao, Kyle Gregory Mitchell, Annikka Weissferdt, Ara A Vaporciyan, Tina Cascone, Jack A Roth, Jianjun Zhang, Boris Sepesi, Don L Gibbons, John V Heymach, Cara L Haymaker, Daniel J McGrail, Alexandre Reuben, Chantale Bernatchez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
BackgroundAdoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TIL) yielded clinical benefit in patients with checkpoint blockade immunotherapy-refractory non-small cell lung cancer (NSCLC) prompting a renewed interest in TIL-ACT. This pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b74ae6bfa57e8e732225d99a2b5e9768
https://pubmed.ncbi.nlm.nih.gov/35110355
https://pubmed.ncbi.nlm.nih.gov/35110355